Cardiovascular Disease Clinical Research  

Reducing the burden of cardiovascular disease in patients

As a leading life-shortening disease, cardiovascular diseases are critical to prevent and treat immediately in patients around the world. The clinical trial process is complicated and full of unknowns, and even the best cardiovascular therapeutic might not make it to the patients that need it, not because it does not work but because the design, data collection, and analysis were not done right.

At Veristat, we have assembled an extraordinary team of scientific-minded experts who have mastered the complexities of running cardiovascular disease trials. We have supported more than 200 projects for cardiovascular treatments, diagnostics, and medical devices.

Improving Cardiovascular Disease Outcomes Through Expertise

The acute nature of most cardiology/vascular diseases makes them highly complex to treat.  Our diverse trial experience, coupled with our knowledgeable and experienced teams, allows us to confidently handle the most complex trials and patient populations with the attention and focus needed to navigate the cardiology/vascular disease landscape.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:     

Background Banner Video

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Explore Our Recent Cardiology Experience

Driving Successful Outcomes for Cardiovascular Trials
   Abdominal Aortic Aneurysm (AAA)     Ehlers-Danlos Syndrome (EDS)     Ischemic Heart Disease 
   Acute Coronary Syndrome    Electrocardiogram (ECG)    Myocardial Infarction
   Acute Hereditary Angioedema Attacks    Endocarditis    Pericarditis
   Blood/Brain Barrier Crossing of Drug    Familial Chylomicronemia Syndrome (FCS)    Raynaud's Disease
   Cardiac Fibrosis    Heart Failure    Stroke - Aneurysmal Subarachnoid Hemorrhage (aSAH)
   Cardiac Imaging    Hereditary Transthyretin Amyloidosis (hATTR)    Treatment after Creation of Arteriovenous Access for Hemodialysis Use
   Coronary Arterial Restenosis    Homozygous Familial Hypercholesterolemia (HoFH)    Vascular Access Graft
   Coronary Artery Bypass Grafting (CABG)    Hyperlipoproteinemia(a) and Established Cardiovascular Disease (CVD)    Vascular Ehlers-Danlos Syndrome (EDS)
   Coronary Artery Disease    Hypertension    Vascular Injury
   Critical Limb Ischemia    Hypertriglyceridemia    Venous Leg Ulcers (VLU)


Learn More with These Resources

Webinar Presentation
Webinar: Virtual Trial Planning Lessons Learned

Get the webinar presentation to see lessons learned and recommendations for designing protocols that enable flexibility in your virtual trials' ...

Case Study
Writing Multiple Marketing Applications At The Same Time

A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s ...

Fact Sheet
Cardiovascular Experience Fact Sheet

With Cardiovascular Diseases being the leading cause of death worldwide, Veristat is committed to supporting cardiovascular clinical trials to make a difference in ...

Request A Proposal